Scale -


  • Revenue is 2324 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 14 %
  • Ebitda is 526 Rs Cr; in Top Quartile; 5 Year CAGR is 11 %
  • PBT is 94.69 Rs Cr; in Top Quartile; 5 Year CAGR is 10 %
  • PAT is 332 Rs Cr; in Top Quartile; 5 Year CAGR is 11 %
  • Quarterly Revenue is 527 Rs Cr; in Top Quartile

Profitability -


  • Quarterly Profit margin is 14 %; Continuous Growth over 3 Quarters; in Top Quartile
  • PBDIT Margin is 22.65 %; in Top Quartile; Annual Decline is -13 %; Continuous Decline over 3 years
  • PAT Margin is 14.26 %; in Top Quartile; Annual Decline is -16 %; Continuous Decline over 3 years
  • Quarterly Ebitda Margin is 19 %; in Top Quartile

Return -


  • ROCE is 16.4 %; in Top Quartile; Continuous Decline over 3 years; 5 Year CAGR is -37 %
  • ROA is 11.03 %; in Top Quartile; Continuous Decline over 3 years
  • ROE is 14.46 %; in Top Quartile; Continuous Decline over 3 years; 5 Year CAGR is -50 %
  • Asset Turnover is 82 %; Continuous Decline over 3 years

Efficiency -


  • Current Ratio is 8.1; in Top Quartile; 5 Year CAGR is 70 %
  • Quick Ratio is 6.11; in Top Quartile; 5 Year CAGR is 79 %
  • Operating cash flow is 255 Rs Cr; in Top Quartile
  • Inventory Turnover Ratio is 4.39; 5 Year CAGR is 30 %

Solvancy -


  • Debt/Equity is 0.02; in Bottom Quartile; 5 Year CAGR is -75 %
  • Long term Debt is 0 Rs Cr; in Bottom Quartile
  • Total Debt is 34.62 Rs Cr; 5 Year CAGR is -47 %; Annual Growth is 6824 %
  • Contingent Liabilities is 95.25 Rs Cr; Annual Growth is 38 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 35 %

Quality -


  • Operating cashflow/ebitda is 48 %; Continuous Growth over 3 years
  • Operating cashflow/PAT is 77 %; Continuous Growth over 3 years
  • Exceptional Items/PBT is -2 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is 1 %; Annual Growth is 132 %
  • Other Expenses/Total Expenses is 23 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Cello World Limited Estimates – NSE:CELLO
What Are Branded Medicine Maker, Group Holding Company and Consumerware Stocks?
Price to book forward of Cello World Limited – NSE:CELLO
Cello World Limited (CELLO.NS) Trades at ?373.4, Up 1.56% as Stock Approaches Key Resistance
Cello World (CELLO.NS) Slips 3.83% to ?375.70, Drifting Toward ?356.91 Support
Cello World NSE:CELLO Reg 74(5) Q2 FY27 Compliance Certificate
Cello World Ltd. Share Price Rise Streak: CELLO up 6.11%
Cello World, Star Health, HEG Advanced Materials shares surge amid spike in volumes
Cello World: Diversifying a Consumer Brand Across Categories